According to Aurinia Pharmaceuticals
's latest financial reports the company has $0.37 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $0.37 B | -6.78% |
2022-12-31 | $0.40 B | -15.37% |
2021-12-31 | $0.47 B | 17.5% |
2020-12-31 | $0.40 B | 36.55% |
2019-12-31 | $0.29 B | 165.25% |
2018-12-31 | $0.11 B | -32.08% |
2017-12-31 | $0.16 B | 361.04% |
2016-12-31 | $35.95 M | 80.08% |
2015-12-31 | $19.96 M | -41.06% |
2014-12-31 | $33.87 M | 154.42% |
2013-12-31 | $13.31 M | -728.56% |
2012-12-31 | $-2.12 M | -133.04% |
2011-12-31 | $6.41 M | 1% |
2010-12-31 | $6.34 M | 32.02% |
2009-12-31 | $4.8 M | -38.9% |
2008-12-31 | $7.87 M | -72.3% |
2007-12-31 | $28.41 M | 40.9% |
2006-12-31 | $20.16 M | -52.39% |
2005-12-31 | $42.35 M | -18.85% |
2004-12-31 | $52.19 M | -23.84% |
2003-12-31 | $68.54 M | 44.12% |
2002-12-31 | $47.55 M | 34.79% |
2001-12-31 | $35.28 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Regeneron Pharmaceuticals REGN | $25.97 B | 6,772.03% | ๐บ๐ธ USA |
Pieris Pharmaceuticals PIRS | $30.51 M | -91.93% | ๐บ๐ธ USA |
Aeterna Zentaris AEZS | $18.19 M | -95.19% | ๐บ๐ธ USA |